Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force

被引:0
|
作者
Botwright, Siobhan [1 ,2 ]
Sittimart, Manit [1 ]
Chavarina, Kinanti Khansa [1 ]
Bayani, Diana Beatriz [3 ]
Merlin, Tracy [4 ]
Surgey, Gavin [5 ]
Suharlim, Christian [6 ]
Espinoza, Manuel A. [7 ]
Culyer, Anthony J. [8 ]
Oortwijn, Wija [5 ]
Teerawattananon, Yot [1 ,3 ]
机构
[1] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program HITAP, Nonthaburi, Thailand
[2] Univ Strathclyde, Glasgow, Scotland
[3] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[4] Univ Adelaide, Adelaide Hlth Technol Assessment AHTA, Adelaide, SA, Australia
[5] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[6] Management Sci Hlth, Medford, MA USA
[7] Pontificia Univ Catolica Chile, Santiago, Chile
[8] Univ York, Ctr Hlth Econ, York, England
关键词
evidence-informed priority setting; good practices; guidelines; HTA; BUDGET IMPACT ANALYSIS; ECONOMIC-EVALUATION; STAKEHOLDER INVOLVEMENT; PRINCIPLES; FRAMEWORK; MODEL; RECOMMENDATIONS; UNCERTAINTY; CONFLICTS; RESOURCE;
D O I
10.1016/j.jval.2024.09.001
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Health technology assessment (HTA) guidelines are intended to support successful implementation of HTA by enhancing consistency and transparency in concepts, methods, process, and use, thereby enhancing the legitimacy of the decision-making process. This report lays out good practices and practical recommendations for developing or updating HTA guidelines to ensure successful implementation. Methods: The task force was established in 2022 and comprised experts and academics from various geographical regions, each with substantial experience in developing HTA guidelines for national health policymaking. Literature reviews and key-informant interviews were conducted to inform these good practices. Stakeholder consultations, open peer reviews, and expert opinions validated the recommendations. A series of teleconferences among task force members was held to iteratively refine the report. Results: The recommendations cover 6 key aspects throughout the guideline development cycle: (1) setting objectives, scope, and principles of the guideline, (2) building a team for a quality guideline, (3) defining a stakeholder engagement plan, (iv) developing content and utilizing available resources, (v) putting in place appropriate institutional arrangements, and (vi) monitoring and evaluating guideline success. Conclusion: This report presents a set of resources and context-appropriate practices for developing or updating HTA guidelines. Across all contexts, the recommendations emphasize transparency, building trust among stakeholders, and fostering a culture of ongoing learning and improvement. The report recommends timing development and revision of guidelines according to the HTA landscape and pace of HTA institutionalization. Because HTA is increasingly used to inform different kinds of decision making in a variety of country contexts, it will be important to continue to monitor lessons learned to ensure the recommendations remain relevant and effective.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [21] Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force
    Tervonen, Tommi
    Veldwijk, Jorien
    Payne, Katherine
    Ng, Xinyi
    Levitan, Bennett
    Lackey, Leila G.
    Marsh, Kevin
    Thokala, Praveen
    Pignatti, Francesco
    Donnelly, Anne
    Ho, Martin
    VALUE IN HEALTH, 2023, 26 (04) : 449 - 460
  • [22] Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
    Bridges, John F. P.
    Hauber, A. Brett
    Marshall, Deborah
    Lloyd, Andrew
    Prosser, Lisa A.
    Regier, Dean A.
    Johnson, F. Reed
    Mauskopf, Josephine
    VALUE IN HEALTH, 2011, 14 (04) : 403 - 413
  • [23] An International Survey of the Public Engagement Practices of Health Technology Assessment Organizations
    Whitty, Jennifer A.
    VALUE IN HEALTH, 2013, 16 (01) : 155 - 163
  • [24] The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries' past health technology assessments
    Vreman, Rick A.
    van Hoof, Daan
    Nachtnebel, Anna
    Daems, Joel
    van de Casteele, Marc
    Fogarty, Emer
    Adams, Roisin
    Timmers, Lonneke
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
  • [25] Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report
    Malone, Daniel C.
    Ramsey, Scott D.
    Patrick, Donald L.
    Johnson, F. Reed
    Mullins, C. Daniel
    Roberts, Mark S.
    Willke, Richard J.
    Marshall, Deborah A.
    VALUE IN HEALTH, 2020, 23 (04) : 409 - 415
  • [26] Health technology assessment report on Robodoc®
    Schräder, P
    ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 2005, 143 (03): : 329 - 336
  • [27] Redefining Health Technology Assessment: A Comment on "The New Definition of Health Technology Assessment: A Milestone in International Collaboration"
    Culyer, Anthony
    Husereau, Don
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2022, 38 (01)
  • [28] Biotechnology: A special case for health technology assessment?
    Mason, J
    Drummond, M
    HEALTH POLICY, 1997, 41 (01) : 73 - 81
  • [29] Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force
    Edgar, Chris J.
    Bush, Elizabeth
    Adams, Heather R.
    Ballinger, Rachel
    Byrom, Bill
    Campbell, Michelle
    Eremenco, Sonya
    McDougall, Fiona
    Papadopoulos, Elektra
    Slagle, Ashley F.
    Coons, Stephen Joel
    VALUE IN HEALTH, 2023, 26 (07) : 959 - 967
  • [30] Development of health technology assessment in Lithuania
    Danguole, Jankauskiene
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 : 140 - 142